Fischer Medical Ventures vs e-Credible Co.: Fair Value & Quality
Both stocks run through our valuation models. Here is how Fischer Medical Ventures (FISCHER) and e-Credible Co. (092130) compare, as of Aug 20, 2026.
As of Aug 20, 2026, Fair Value Calculator sees e-Credible Co. as the more attractively valued of the two: Fischer Medical Ventures trades at ₹38.88 versus a fair value of ₹6.85 (-82%), while e-Credible Co. trades at KRW 14,170 versus KRW 21,145 (+49%).
Fischer Medical Ventures
FISCHER.BSE · INR · Industrials
-82%
upside to fair value
overvalued
Price₹38.88
Fair Value₹6.85
Quality40/100
e-Credible Co.
092130.KQ · KRW · Industrials
+49%
upside to fair value
undervalued
PriceKRW 14,170
Fair ValueKRW 21,145
Quality89/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Fischer Medical Venturese-Credible Co.
Valuation
86.4×P/E (TTM)—
8.34×P/S (TTM)—
6.69×P/B—
62.8×EV/EBITDA—
0.1%Dividend yield5.8%
₹0.05Dividend per share—
Profitability
10%Net margin31%
0%Operating margin40%
9%Return on equity—
4%Return on assets18%
Growth
99%Revenue growth (YoY)1%
1,097.9%Avg. growth/yr (3Y)2.0%
351.2%Avg. growth/yr (5Y)3.1%
Balance & size
0.00×Debt / equity—
$268MMarket cap$119M
mixedGrowth qualityhealthy
e-Credible Co. leads: 3 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Fischer Medical Venturesof which business quality 41 · market factors 30e-Credible Co.of which business quality 86 · market factors 49
ProfitabilityMargins and returns on capital today
37
94
Quality GrowthAre margins and returns improving?
89
70
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
50
95
Low VolatilityCalm price path (market factor)
57
98
MomentumPrice trend over the last 3–12 months (market factor)
26
32
52W MomentumDistance to the 52-week high (market factor)
4
21
Net IssuanceBuybacks instead of dilution
0
82
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Fischer Medical Ventures
DCF Models₹18.02
Earnings-Based₹16.59
Dividend Discount₹0.08
Multiples₹8.44
Asset-Based₹3.93
Economic Profit₹6.12
Growth Earnings₹21.70
17 of 17 models see the stock below the current price.
e-Credible Co.
DCF ModelsKRW 20,498
Earnings-BasedKRW 10,439
MultiplesKRW 18,553
Asset-BasedKRW 2,377
Growth DCFKRW 16,242
Economic ProfitKRW 11,899
Growth EarningsKRW 20,152
10 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Fischer Medical Ventures
Bear ₹3.77Fair Value ₹6.85Bull ₹8.56
₹38.88 = current price (white tick)
e-Credible Co.
Bear KRW 14,577Fair Value KRW 21,145Bull KRW 26,198
KRW 14,170 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Fischer Medical Ventures · Industrials
Quality score40 · bottom 25%
Fair value upside-82% · bottom 25%
e-Credible Co. · Industrials
Quality score89 · Top 25%
Fair value upside+49% · Top 25%
Bottom line
As of Aug 20, 2026, Fair Value Calculator sees e-Credible Co. as the more attractively valued of the two: Fischer Medical Ventures trades at ₹38.88 versus a fair value of ₹6.85 (-82%), while e-Credible Co. trades at KRW 14,170 versus KRW 21,145 (+49%).
e-Credible Co. has the higher quality score (89/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
